Leslie Hodges-Gallagher

981 total citations
24 papers, 804 citations indexed

About

Leslie Hodges-Gallagher is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Leslie Hodges-Gallagher has authored 24 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Leslie Hodges-Gallagher's work include Estrogen and related hormone effects (16 papers), Endometriosis Research and Treatment (5 papers) and Advanced Breast Cancer Therapies (4 papers). Leslie Hodges-Gallagher is often cited by papers focused on Estrogen and related hormone effects (16 papers), Endometriosis Research and Treatment (5 papers) and Advanced Breast Cancer Therapies (4 papers). Leslie Hodges-Gallagher collaborates with scholars based in United States. Leslie Hodges-Gallagher's co-authors include Peter J. Kushner, Cathleen D. Valentine, Cheryl L. Walker, Robin Fuchs‐Young, Deborah Hunter, S.K. Chan, Roger A. Laine, Peter M. Vonier, Cheryl L. Walker and Pierre R. Bushel and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Leslie Hodges-Gallagher

24 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Hodges-Gallagher United States 15 360 306 189 136 127 24 804
Donald C. Henley United States 11 438 1.2× 233 0.8× 283 1.5× 73 0.5× 74 0.6× 14 883
Hiroki Hata Japan 15 301 0.8× 318 1.0× 169 0.9× 121 0.9× 172 1.4× 35 767
Y. Nishino Germany 18 229 0.6× 517 1.7× 163 0.9× 137 1.0× 41 0.3× 53 798
Matty Meijers Netherlands 17 879 2.4× 152 0.5× 268 1.4× 102 0.8× 67 0.5× 23 1.2k
Françoise Caira France 17 481 1.3× 192 0.6× 321 1.7× 60 0.4× 35 0.3× 31 1.0k
Surojeet Sengupta United States 18 437 1.2× 289 0.9× 283 1.5× 24 0.2× 19 0.1× 33 864
Arwed Cleve Germany 10 269 0.7× 103 0.3× 76 0.4× 65 0.5× 34 0.3× 21 547
Maud Marques Canada 17 647 1.8× 86 0.3× 202 1.1× 47 0.3× 26 0.2× 26 914
Thomas J. Berrodin United States 17 639 1.8× 655 2.1× 177 0.9× 87 0.6× 24 0.2× 23 1.1k
Ella Twaddle Australia 12 117 0.3× 313 1.0× 96 0.5× 76 0.6× 44 0.3× 16 455

Countries citing papers authored by Leslie Hodges-Gallagher

Since Specialization
Citations

This map shows the geographic impact of Leslie Hodges-Gallagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Hodges-Gallagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Hodges-Gallagher more than expected).

Fields of papers citing papers by Leslie Hodges-Gallagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Hodges-Gallagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Hodges-Gallagher. The network helps show where Leslie Hodges-Gallagher may publish in the future.

Co-authorship network of co-authors of Leslie Hodges-Gallagher

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Hodges-Gallagher. A scholar is included among the top collaborators of Leslie Hodges-Gallagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Hodges-Gallagher. Leslie Hodges-Gallagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodges-Gallagher, Leslie, Fabian E. Ortega, David Kulp, et al.. (2023). Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular Cancer Therapeutics. 23(3). 285–300. 21 indexed citations
2.
3.
Hodges-Gallagher, Leslie, David C. Myles, Pamela Klein, et al.. (2021). Abstract PS18-16: The complete estrogen receptor antagonist OP-1250 shrinks tumors in xenograft models and has favorable preclinical pharmacokinetic attributes. Cancer Research. 81(4_Supplement). PS18–16. 3 indexed citations
4.
Hodges-Gallagher, Leslie, David C. Myles, Pamela Klein, et al.. (2020). OP-1250: A potent orally available complete antagonist of estrogen receptor-mediated signaling that shrinks wild type and mutant breast tumors. European Journal of Cancer. 138. S55–S55. 7 indexed citations
5.
6.
Fanning, Sean W., Leslie Hodges-Gallagher, David C. Myles, et al.. (2018). Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity. Nature Communications. 9(1). 2368–2368. 41 indexed citations
7.
Zavodovskaya, Marianna, Michael J. Campbell, Betty A. Maddux, et al.. (2007). Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF‐1 receptor tyrosine kinases, blocks the growth of HER2‐overexpressing human breast cancer cells. Journal of Cellular Biochemistry. 103(2). 624–635. 42 indexed citations
8.
Hodges-Gallagher, Leslie, et al.. (2007). Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Research and Treatment. 109(2). 241–250. 83 indexed citations
9.
Hodges-Gallagher, Leslie, et al.. (2006). Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. Breast Cancer Research and Treatment. 105(3). 297–309. 90 indexed citations
10.
Kroetz, Deanna L., et al.. (2005). Heritability of digoxin pharmacokinetics. Clinical Pharmacology & Therapeutics. 77(2). P21–P21. 1 indexed citations
11.
Hodges-Gallagher, Leslie, Jennifer Cook, Edward K. Lobenhofer, et al.. (2003). Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells.. PubMed. 1(4). 300–11. 104 indexed citations
12.
Hodges-Gallagher, Leslie, Kevin D. Houston, Deborah Hunter, et al.. (2002). Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Molecular and Cellular Endocrinology. 196(1-2). 11–20. 30 indexed citations
13.
Hodges-Gallagher, Leslie, et al.. (2001). An in vivo/in vitro Model to Assess Endocrine Disrupting Activity of Xenoestrogens in Uterine Leiomyoma. Annals of the New York Academy of Sciences. 948(1). 100–111. 21 indexed citations
14.
Zenklusen, Jean C., Leslie Hodges-Gallagher, Margaret LaCava, Eric D. Green, & Claudio J. Conti. (2000). Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene. 19(13). 1729–1733. 32 indexed citations
15.
Hunter, Deborah, Leslie Hodges-Gallagher, Patricia K. Eagon, et al.. (2000). Influence of Exogenous Estrogen Receptor Ligands on Uterine Leiomyoma: Evidence from an in Vitro/in Vivo Animal Model for Uterine Fibroids. Environmental Health Perspectives. 108(s5). 829–834. 37 indexed citations
16.
Hodges-Gallagher, Leslie. (2000). Estrogenic Effects of Organochlorine Pesticides on Uterine Leiomyoma Cells in Vitro. Toxicological Sciences. 54(2). 355–364. 97 indexed citations
17.
Hunter, Deborah, Leslie Hodges-Gallagher, Patricia K. Eagon, et al.. (2000). Influence of Exogenous Estrogen Receptor Ligands on Uterine Leiomyoma: Evidence from an in Vitro/in Vivo Animal Model for Uterine Fibroids. Environmental Health Perspectives. 108. 829–829. 8 indexed citations
18.
Walker, Cheryl L., S. Ansar Ahmed, Tom Brown, et al.. (1999). Species, interindividual, and tissue specificity in endocrine signaling.. Environmental Health Perspectives. 107(suppl 4). 619–624. 16 indexed citations
19.
Zenklusen, Jean C., Leslie Hodges-Gallagher, & Claudio J. Conti. (1997). Loss of heterozygosity on murine chromosome 6 in two-stage carcinogenesis: evidence for a conserved tumor suppressor gene. Oncogene. 14(1). 109–114. 9 indexed citations
20.
Hodges-Gallagher, Leslie, Roger A. Laine, & S.K. Chan. (1979). Structure of the oligosaccharide chains in human alpha 1-protease inhibitor.. Journal of Biological Chemistry. 254(17). 8208–8212. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald C. Henley Breakdown of academic impact, for papers by Hiroki Hata Breakdown of academic impact, for papers by Y. Nishino Breakdown of academic impact, for papers by Matty Meijers Breakdown of academic impact, for papers by Françoise Caira Breakdown of academic impact, for papers by Surojeet Sengupta Breakdown of academic impact, for papers by Arwed Cleve Breakdown of academic impact, for papers by Maud Marques Breakdown of academic impact, for papers by Thomas J. Berrodin Breakdown of academic impact, for papers by Ella Twaddle
Rankless by CCL
2026